Clinical Perspectives

Managing Common Non-Malignant Hematologic Disorders at Moffitt

Beyond Moffitt's expertise in malignant hematology, we also partner with community healthcare providers to treat complex, non-cancerous blood...

Now Open: Moffitt at Speros Outpatient Center in Pasco County

Moffitt at Speros represents the beginning of a significant expansion of access to NCI-designated Comprehensive Cancer Center care for patients in...

Merlin Test Refines Melanoma SLNB Selection

The gene expression test accurately identifies low-risk patients who can avoid sentinel node biopsy.

The 2-3 Week Rule: When “Persistent” Symptoms Deserve a Cancer Evaluation

Learn how to spot subtle signs of head and neck cancers to refer patients to Moffitt and save lives.

Direct Access to our Transplant and Cellular Immunotherapy Experts

When patients face challenging malignant or non-malignant hematologic diseases, timely referral to specialized care can make all the difference in...

The Critical Role of Surgeon Selection in Cancer Outcomes

Moffitt Cancer Center performs 850-900 cancer surgeries monthly. This case volume supports genuine subspecialization, where surgeons focus...

Oncoplastic Surgery: Advancement in Breast Cancer Surgery

As a referring provider, it's crucial to understand that oncoplastic surgery is now an integral component of all breast cancer surgeries

Expanding Access: Cellular Therapies and Autologous Stem Cell Transplants for Treatment-Resistant Autoimmune Disease

Moffitt has launched a new service specifically for non-cancer patients with autoimmune diseases like MS and SSc or Scleroderma who have relapsed...

New Treatments for Breast Cancer Leptomeningeal Disease Using the Patients' Own Immune Cells

LMD often emerges paradoxically when the systemic disease appears well-controlled, it creates a devastating disconnect between overall cancer...

Personalized Breast Cancer Immunotherapy Trials

In the evolving landscape of breast cancer treatment, two groundbreaking clinical trials at Moffitt are offering new hope to patients with aggressive...

Expanding Treatment Horizons: Moffitt's Approach to Stage IV Esophageal Cancer Surgery

Historically, surgery has been considered inappropriate for patients with stage IV esophageal cancer, but Moffitt's experts suggested that...

Improving Survival Rates in Esophageal Cancer: Why Early Referral Matters

Early referral to Moffitt provides esophageal cancer patients access to world-class GI cancer expertise.

Expanding Minimally Invasive Options for Lung Metastases: The Role of Thermal Ablation

Moffitt Cancer Center has been working to expand access to thermal ablation for appropriate patients in the Southeast.

6 Common Bone Marrow Transplant Misconceptions for Leukemia Patients

If you have a patient with leukemia or hematologic malignancy, but you are unsure if they are eligible for bone marrow transplant, we encourage you...

The Power of Investigator-Initiated Trials

Discover how physician-led clinical trials at Moffitt are driving cancer breakthroughs and giving more patients access to promising new therapies.